高级搜索

18F-FDG PET/CT代谢参数与结直肠癌临床病理特征的关系

宋金龄, 李忠武, 卫毛毛, 周妮娜, 杨志, 王雪鹃

宋金龄, 李忠武, 卫毛毛, 周妮娜, 杨志, 王雪鹃. 18F-FDG PET/CT代谢参数与结直肠癌临床病理特征的关系[J]. 肿瘤防治研究, 2019, 46(11): 1006-1012. DOI: 10.3971/j.issn.1000-8578.2019.19.0665
引用本文: 宋金龄, 李忠武, 卫毛毛, 周妮娜, 杨志, 王雪鹃. 18F-FDG PET/CT代谢参数与结直肠癌临床病理特征的关系[J]. 肿瘤防治研究, 2019, 46(11): 1006-1012. DOI: 10.3971/j.issn.1000-8578.2019.19.0665
SONG Jinling, LI Zhongwu, WEI Maomao, ZHOU Ni'na, YANG Zhi, WANG Xuejuan. Relation Between Metabolic Parameters of 18F-FDG PET/CT and Clinicopathological Features of Colorectal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 1006-1012. DOI: 10.3971/j.issn.1000-8578.2019.19.0665
Citation: SONG Jinling, LI Zhongwu, WEI Maomao, ZHOU Ni'na, YANG Zhi, WANG Xuejuan. Relation Between Metabolic Parameters of 18F-FDG PET/CT and Clinicopathological Features of Colorectal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 1006-1012. DOI: 10.3971/j.issn.1000-8578.2019.19.0665

18F-FDG PET/CT代谢参数与结直肠癌临床病理特征的关系

详细信息
    作者简介:

    宋金龄(1992-),女,硕士,住院医师,主要从事肿瘤核医学研究

    通信作者:

    王雪鹃(1974-),女,博士,主任医师,主要从事肿瘤核医学研究,E-mail:xuejuan_wang@hotmail.com

  • 中图分类号: R735.3

Relation Between Metabolic Parameters of 18F-FDG PET/CT and Clinicopathological Features of Colorectal Cancer Patients

More Information
  • 摘要:
    目的 

    探讨18F-FDG PET/CT代谢参数与结直肠癌临床病理特征的关系。

    方法 

    纳入358例CRC患者行治疗前18F-FDG PET/CT显像,测量CRC原发灶最大标准摄取值、平均标准摄取值、肿瘤代谢体积和病灶糖酵解总量,分析其与原发灶位置、病理特征及TNM分期的关系。

    结果 

    结肠癌原发灶MTV及TLG值最高,乙状结肠癌次之,直肠癌最低,组间差异有统计学意义(P < 0.001)。低/中低分化直肠癌SUVmax值高于中/高分化直肠癌(P=0.028)。黏液腺癌原发灶MTV值较普通型腺癌大(P=0.023)。T4期原发灶MTV和TLG值高于T2-3期病灶(P=0.0001, P=0.007)。存在远处转移的乙状结肠癌原发灶SUVmax及SUVmean低于无远处转移者(P=0.015, P=0.011)。

    结论 

    CRC原发灶代谢参数与位置、病理特征及TNM分期相关,能部分反映肿瘤病理特征,揭示CRC异质性。

     

    Abstract:
    Objective 

    To investigate the relation between 18F-FDG PET/CT metabolic parameters and the clinicopathological characteristics of colorectal cancer (CRC) patients.

    Methods 

    We included 358 CRC patients who met the admission criteria. 18F-FDG PET/CT scans were performed before any treatment. Maximum standard uptake, average standard uptake, tumor metabolic volume (MTV) and total glycolysis (TLG) of the primary lesion of CRC were measured and calculated. The correlation of metabolic parameters with lesion location, pathological profile and TNM staging were investigated through Mann-Whitney U test and Kruskal-Wallis test.

    Results 

    The MTV and TLG values in the primary foci of colon cancer were the highest, followed by sigmoid cancer and the lowest in rectal cancer, with statistically significant differences between the groups (P < 0.001). SUVmax values of poorly/poorly-moderately differentiated colorectal cancer were higher than those of moderately/well differentiated colorectal cancer (P=0.028). MTV values of primary mucinous adenocarcinoma were higher than those of primary adenocarcinoma (P=0.023). MTV and TLG values were higher in T4 lesions than those in T2-3 lesions (P=0.0001, P=0.007); SUVmax and SUVmean values of sigmoid carcinoma with distant metastasis were lower than those without distant metastasis(P=0.015, P=0.011).

    Conclusion 

    The metabolic parameters of CRC are correlated with the lesion location, pathological features and TNM staging, which could partly reflect the pathological characteristics and heterogeneity of CRC.

     

  • 作者贡献
    宋金龄:数据收集、统计及文章撰写
    李忠武:病理及免疫组织化学诊断
    卫毛毛:数据收集
    周妮娜:数据统计
    杨志:PET/CT扫描质控及数据校对
    王雪鹃:数据校对及文章修改
  • 图  1   结肠癌、乙状结肠癌及直肠癌原发灶的肿瘤负荷常数

    Figure  1   Tumor load constant of primary lesions of colon cancer, sigmoid cancer and rectal cancer

    图  2   左右半结肠原发灶的肿瘤负荷常数

    Figure  2   Tumor load constant of primary lesions of left and right hemicolon

    图  3   直肠癌分化程度与SUVmax值的关系

    Figure  3   Relation between differentiation and SUVmax of rectal cancer

    表  1   358例结直肠癌患者基本临床病理特征(n(%))

    Table  1   Clinicopathologic features of 358 colorectal cancer (CRC) patients (n(%))

    下载: 导出CSV

    表  2   原发灶代谢参数与分化程度及Ki-67表达的关系

    Table  2   Correlation of primary metabolic parameters with differentiation and Ki-67 expression

    下载: 导出CSV

    表  3   原发灶代谢参数与TNM分期的关系

    Table  3   Relation between primary metabolic parameters and TNM stage

    下载: 导出CSV
  • [1]

    Schinagl DA, Vogel WV, Hoffmann AL, et al. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer[J]. Int J Radiat Oncol Biol Phys, 2007, 69(4): 1282-1289. doi: 10.1016/j.ijrobp.2007.07.2333

    [2]

    Haraldsdottir S, Einarsdottir HM, Smaradottir A, et al. Colorectal cancer-review[J]. Laeknabladid, 2014, 100(2): 75-82. http://d.old.wanfangdata.com.cn/Periodical/gwyx-zlxfc201506008

    [3] 田蓉蓉, 薄云峰, 张毅勋, 等. 18F-FDG PET/CT显像与结直肠癌治疗前分期的相关性研究[J].国际放射医学核医学杂志, 2018, 42(1): 9-14. doi: 10.3760/cma.j.issn.1673-4114.2018.01.002

    Tian RR, Bo YF, Zhang YX, et al. Correlation between 18F-FDG PET/CT and pretreatment staging of colorectal cancer[J]. Guo Ji Fang She Yi Xue He Yi Xue Za Zhi, 2018, 42(1): 9-14. doi: 10.3760/cma.j.issn.1673-4114.2018.01.002

    [4]

    Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0[J]. Eur J Nucl Med Mol Imaging, 2015, 42(2): 328-354. doi: 10.1007/s00259-014-2961-x

    [5]

    Lucignani G. SUV and segmentation: pressing challenges in tumour assessment and treatment[J]. Eur J Nucl Med Mol Imaging, 2009, 36(4): 715-720. doi: 10.1007/s00259-009-1085-1

    [6]

    Hatt M, Visvikis D, Albarghach NM, et al. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology[J]. Eur J Nucl Med Mol Imaging, 2011, 38(7): 1191-1202. doi: 10.1007/s00259-011-1755-7

    [7] 李艳, 马红霞, 王瑞峰, 等. 18F-FDG PET/CT的SUV值与肺癌患者的临床特征、病理类型及肿瘤标记物的关系研究[J].中华临床医师杂志(电子版), 2012, 6(21): 6881-6884. doi: 10.3877/cma.j.issn.1674-0785.2012.21.058

    Li Y, Ma HX, Wang RF, et al. Relationship between SUV value of 18F-FDG PET/CT and clinical characteristics, pathological types and tumor markers of lung cancer patients[J]. Zhonghua Lin Chuang Yi Shi Za Zhi (Dian Zi Ban), 2012, 6(21): 6881-6884. doi: 10.3877/cma.j.issn.1674-0785.2012.21.058

    [8]

    Chang Y, Fu X, Sun Z, et al. Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase[J]. Sci Rep, 2017, 7: 41057. doi: 10.1038/srep41057

    [9]

    Uchiyama S, Haruyama Y, Asada T, et al. Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers[J]. Surg Today, 2012, 42(10): 956-961. doi: 10.1007/s00595-012-0225-6

    [10] 王晓燕, 彭贵娟, 张祥松, 等.基于18氟-脱氧葡萄糖正电子发射计算机断层成像术的最大标准化摄取值和放射线基线比值与结直肠癌术后预后的关系[J].中华胃肠外科杂志, 2015, 18(3): 232-237. doi: 10.3760/cma.j.issn.1671-0274.2015.03.008

    Wang XY, Peng GJ, Zhang XS, et al. Correlation of 18F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2015, 18(3): 232-237. doi: 10.3760/cma.j.issn.1671-0274.2015.03.008

    [11] 李院江, 罗林海.左、右半结肠癌患者临床病理特点及预后差异分析[J].中外医疗, 2018, 37(24): 20-22. http://d.old.wanfangdata.com.cn/Periodical/zhyx201528006

    Li YJ, Luo LH. Clinical and Pathological Features and Prognosis of Patients with Left and Right Colon Cancer[J]. Zhong Wai Yi Liao, 2018, 37(24): 20-22. http://d.old.wanfangdata.com.cn/Periodical/zhyx201528006

    [12]

    Chen SW, Chen WT, Wu YC, et al. Which FDG/PET parameters of the primary tumors in colon or sigmoid cancer provide the best correlation with the pathological findings?[J]. Eur J Radiol, 2013, 82(9): e405-e410. doi: 10.1016/j.ejrad.2013.04.022

    [13]

    Lee HS, Kim HO, Hong YS, et al. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery[J]. J Nucl Med, 2014, 55(4): 582-589. doi: 10.2967/jnumed.113.128629

    [14]

    Wang L, Liu Z, Fisher KW, et al. Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer[J]. Hum Pathol, 2018, 71: 20-29. doi: 10.1016/j.humpath.2017.07.014

    [15]

    Güreşci S, Özmen Ö, Uzman M, et al. Correlation of Ki-67 proliferation index and 18-fluorodeoxyglucose uptake in colorectal incidental lesions detected by positron emission tomography-computed tomography[J]. Turk J Med Sci, 2016, 46(4): 1182-1187. http://cn.bing.com/academic/profile?id=0ca9e1b5795bc7aad9917e92ba7e081a&encoded=0&v=paper_preview&mkt=zh-cn

    [16]

    Sugarbaker PH. Mucinous colorectal carcinoma[J]. J Surg Oncol, 2001, 77(4): 282-283. doi: 10.1002/jso.1111

    [17]

    Gonzalez RS, Cates JMM, Washington K. Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component[J]. Histopathology, 2019, 74(3): 406-414. doi: 10.1111/his.13748

    [18] 杨明, 冯彦林, 冼伟均, 等.应用18F-FDG PET/CT评估不同CD5表达的弥漫大B细胞淋巴瘤化疗疗效及价值[J].肿瘤防治研究, 2019, 46(10): 926-931. doi: 10.3971/j.issn.1000-8578.2019.19.0444

    Yang M, Feng YL, Xian WJ, et al. Value of 18F-FDG PET/CT in evaluating chemotherapeutic effect of diffuse large B cell lymphoma patients with different CD5 expression[J]. Zhong Liu Fang Zhi Yan Jiu, 2019, 46(10): 926-931. doi: 10.3971/j.issn.1000-8578.2019.19.0444

图(3)  /  表(3)
计量
  • 文章访问数:  2394
  • HTML全文浏览量:  615
  • PDF下载量:  427
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-05-20
  • 修回日期:  2019-08-13
  • 网络出版日期:  2024-01-12
  • 刊出日期:  2019-11-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭